Sakar Healthcare Ltd.
•₹ 912.63.16%
2026-08-21
PROS
- Latest quarter profit grew 120.2% YoY, showing strong momentum
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 16.4% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.19x)
- Operating margins have improved to 28.0% from 24.6%
CONS
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of 8.3%
- Company has a low return on equity of 6.8% over last 3 years
- Equity base is being diluted - shares outstanding up 28.2%
- Though reporting repeated profits, the company pays out little dividend (0.0%)
- Inventory has been piling up - inventory days up from 51 to 73
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SAKAR | 871.00 | 53.69 | 1937.97 | 0.00 | 102.85 | 2101.88 | 729.72 | 1283.72 | 8.43 | 29.12 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 34 | 37 | 43 | 41 | 43 | 43 | 50 | 53 | 58 | 70 | 71 | 73 | |
| 30 | 25 | 28 | 32 | 30 | 31 | 32 | 35 | 40 | 46 | 52 | 45 | 60 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 |
| Interest | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 4 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 5 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 |
| 4 | 4 | 3 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 11 | 18 | 15 | |
| Tax % | 28.10% | 12.53% | 31.00% | 34.79% | 48.72% | 6.26% | 17.15% | 7.69% | 13.17% | 15.30% | 6.39% | 38.98% | 29.47% |
| Net Profit | 0 | 0 | 0 | 0 | 2 | 5 | 5 | 6 | 5 | 5 | 10 | 11 | 10 |
| 1 | 2 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 5 | 5 | 0 | |
| Equity Capital | 19 | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 19 | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 39
- 30
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 5
- 4
- Tax %
- 28.10%
- Net Profit
- 0
- 1
- Equity Capital
- 19
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 19
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 34
- 25
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 4
- 4
- Tax %
- 12.53%
- Net Profit
- 0
- 2
- Equity Capital
- 21
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 21
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 37
- 28
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 3
- Tax %
- 31.00%
- Net Profit
- 0
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 43
- 32
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 5
- 5
- Tax %
- 34.79%
- Net Profit
- 0
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 41
- 30
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- 5
- Tax %
- 48.72%
- Net Profit
- 2
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 43
- 31
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 5
- 5
- Tax %
- 6.26%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 43
- 32
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- 5
- Tax %
- 17.15%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 50
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 4
- Depreciation
- 5
- 6
- Tax %
- 7.69%
- Net Profit
- 6
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 53
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 6
- 5
- Tax %
- 13.17%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 58
- 46
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 6
- 5
- Tax %
- 15.30%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 70
- 52
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 6
- 11
- Tax %
- 6.39%
- Net Profit
- 10
- 5
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 71
- 45
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 6
- 18
- Tax %
- 38.98%
- Net Profit
- 11
- 5
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 73
- 60
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 7
- 15
- Tax %
- 29.47%
- Net Profit
- 10
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 83 | 95 | 128 | 133 | 153 | 178 | 272 | |
| 63 | 72 | 99 | 100 | 115 | 128 | 203 | |
| Operating Profit | 22 | 24 | 32 | 38 | 42 | 51 | — |
| OPM % | 26 | 25 | 25 | 28 | 27 | 29 | — |
| Other Income | 2 | 1 | 2 | 5 | 3 | 1 | 3 |
| Interest | 2 | 2 | 3 | 6 | 8 | 9 | 7 |
| Depreciation | 7 | 8 | 10 | 15 | 18 | 21 | 25 |
| 12 | 13 | 19 | 17 | 16 | 22 | 49 | |
| Tax % | 21 | 19 | 20 | 25 | 27 | 19 | 26 |
| Net Profit | 10 | 11 | 15 | 13 | 12 | 18 | 36 |
| EPS | 0 | 7 | 9 | 7 | 5 | 8 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 7 | 9 | 7 | 5 | 8 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 7 | 9 | 7 | 5 | 8 | — |
Mar 2020
- 83
- 63
- Operating Profit
- 22
- OPM %
- 26
- Other Income
- 2
- Interest
- 2
- Depreciation
- 7
- 12
- Tax %
- 21
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2021
- 95
- 72
- Operating Profit
- 24
- OPM %
- 25
- Other Income
- 1
- Interest
- 2
- Depreciation
- 8
- 13
- Tax %
- 19
- Net Profit
- 11
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2022
- 128
- 99
- Operating Profit
- 32
- OPM %
- 25
- Other Income
- 2
- Interest
- 3
- Depreciation
- 10
- 19
- Tax %
- 20
- Net Profit
- 15
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2023
- 133
- 100
- Operating Profit
- 38
- OPM %
- 28
- Other Income
- 5
- Interest
- 6
- Depreciation
- 15
- 17
- Tax %
- 25
- Net Profit
- 13
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2024
- 153
- 115
- Operating Profit
- 42
- OPM %
- 27
- Other Income
- 3
- Interest
- 8
- Depreciation
- 18
- 16
- Tax %
- 27
- Net Profit
- 12
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2025
- 178
- 128
- Operating Profit
- 51
- OPM %
- 29
- Other Income
- 1
- Interest
- 9
- Depreciation
- 21
- 22
- Tax %
- 19
- Net Profit
- 18
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
TTM
- 272
- 203
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 7
- Depreciation
- 25
- 49
- Tax %
- 26
- Net Profit
- 36
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 16%
- 3 Years:
- 11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 13%
- 3 Years:
- 5%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 40%
- 3 Years:
- 39%
- 1 Year:
- 176%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 9%
- 3 Years:
- 7%
- Last Year:
- 6%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - |
| Equity Capital | 15 | 16 | 17 | 19 | 22 | 22 |
| 66 | 83 | 110 | 154 | 236 | 261 | |
| 2 | 2 | 5 | 13 | 14 | 21 | |
| Trade Payables | 5 | 20 | 31 | 26 | 27 | 21 |
| 26 | 58 | 105 | 124 | 90 | 90 | |
| Total Liabilities | 115 | 178 | 268 | 336 | 389 | 415 |
| ASSETS | - | - | - | - | - | - |
| 66 | 69 | 205 | 267 | 314 | 309 | |
| Capital Work in Progress | 13 | 49 | 1 | 6 | 0 | 17 |
| 0 | 0 | 7 | 3 | 0 | 0 | |
| 11 | 16 | 14 | 15 | 28 | 44 | |
| 0 | 0 | 0 | 0 | 21 | 31 | |
| 25 | 44 | 41 | 44 | 25 | 15 | |
| Total Assets | 115 | 178 | 268 | 336 | 389 | 415 |
| Total Debt | 17 | 43 | 93 | 119 | 79 | 86 |
| Net Working Capital | 7 | 0 | 3 | 1 | 13 | 26 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 54.35 | 63.04 | 74.45 | 91.04 | 118.41 | 128.75 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 17 | 43 | 93 | 119 | 79 | 86 |
| Net Working Capital | 7 | 0 | 3 | 1 | 13 | 26 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 54.35 | 63.04 | 74.45 | 91.04 | 118.41 | 128.75 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2020
- Equity Capital
- 15
- 66
- 2
- Trade Payables
- 5
- 26
- Total Liabilities
- 115
- 66
- Capital Work in Progress
- 13
- 0
- 11
- 0
- 25
- Total Assets
- 115
- Total Debt
- 17
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 54.35
- Face Value
- 10.00
- Total Debt
- 17
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 54.35
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 16
- 83
- 2
- Trade Payables
- 20
- 58
- Total Liabilities
- 178
- 69
- Capital Work in Progress
- 49
- 0
- 16
- 0
- 44
- Total Assets
- 178
- Total Debt
- 43
- Net Working Capital
- 0
- Contingent Liabilities
- 0
- Book Value per Share
- 63.04
- Face Value
- 10.00
- Total Debt
- 43
- Net Working Capital
- 0
- Contingent Liabilities
- 0
- Book Value per Share
- 63.04
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 17
- 110
- 5
- Trade Payables
- 31
- 105
- Total Liabilities
- 268
- 205
- Capital Work in Progress
- 1
- 7
- 14
- 0
- 41
- Total Assets
- 268
- Total Debt
- 93
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 74.45
- Face Value
- 10.00
- Total Debt
- 93
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 74.45
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 19
- 154
- 13
- Trade Payables
- 26
- 124
- Total Liabilities
- 336
- 267
- Capital Work in Progress
- 6
- 3
- 15
- 0
- 44
- Total Assets
- 336
- Total Debt
- 119
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 91.04
- Face Value
- 10.00
- Total Debt
- 119
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 91.04
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 22
- 236
- 14
- Trade Payables
- 27
- 90
- Total Liabilities
- 389
- 314
- Capital Work in Progress
- 0
- 0
- 28
- 21
- 25
- Total Assets
- 389
- Total Debt
- 79
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 118.41
- Face Value
- 10.00
- Total Debt
- 79
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 118.41
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 22
- 261
- 21
- Trade Payables
- 21
- 90
- Total Liabilities
- 415
- 309
- Capital Work in Progress
- 17
- 0
- 44
- 31
- 15
- Total Assets
- 415
- Total Debt
- 86
- Net Working Capital
- 26
- Contingent Liabilities
- 0
- Book Value per Share
- 128.75
- Face Value
- 10.00
- Total Debt
- 86
- Net Working Capital
- 26
- Contingent Liabilities
- 0
- Book Value per Share
- 128.75
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 19 | 15 | 36 | 33 | 24 | 34 | |
| Cash from Investing | -22 | -47 | -90 | -74 | -52 | -31 |
| Cash from Financing | 3 | 32 | 55 | 41 | 27 | -3 |
| -0 | -0 | -0 | 0 | 0 | -0 | |
| Free Cash Flow | 19 | -33 | -62 | -41 | -35 | 2 |
| OCF / Net Profit | 1.96 | 1.36 | 2.35 | 2.61 | 2.10 | 1.94 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -169 |
| OCF / Net Profit | 1.96 | 1.36 | 2.35 | 2.61 | 2.10 | 1.94 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -169 |
Mar 2020
- 19
- Cash from Investing
- -22
- Cash from Financing
- 3
- -0
- Free Cash Flow
- 19
- OCF / Net Profit
- 1.96
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.96
- Cumulative 5-Year FCF
- 0
Mar 2021
- 15
- Cash from Investing
- -47
- Cash from Financing
- 32
- -0
- Free Cash Flow
- -33
- OCF / Net Profit
- 1.36
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.36
- Cumulative 5-Year FCF
- 0
Mar 2022
- 36
- Cash from Investing
- -90
- Cash from Financing
- 55
- -0
- Free Cash Flow
- -62
- OCF / Net Profit
- 2.35
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.35
- Cumulative 5-Year FCF
- 0
Mar 2023
- 33
- Cash from Investing
- -74
- Cash from Financing
- 41
- 0
- Free Cash Flow
- -41
- OCF / Net Profit
- 2.61
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.61
- Cumulative 5-Year FCF
- 0
Mar 2024
- 24
- Cash from Investing
- -52
- Cash from Financing
- 27
- 0
- Free Cash Flow
- -35
- OCF / Net Profit
- 2.10
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.10
- Cumulative 5-Year FCF
- 0
Mar 2025
- 34
- Cash from Investing
- -31
- Cash from Financing
- -3
- -0
- Free Cash Flow
- 2
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- -169
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- -169
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - |
| EPS (₹) | 6.43 | 6.84 | 8.87 | 6.70 | 5.37 | 7.97 |
| Book Value (₹) | 54.35 | 63.04 | 74.45 | 91.04 | 118.41 | 128.75 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 11.16 | 12.00 | 14.52 | 14.57 | 13.66 | 17.49 |
| PROFITABILITY | - | - | - | - | - | - |
| Operating Margin % | 25.99% | 25.11% | 24.57% | 28.45% | 25.03% | 27.99% |
| Net Margin % | 11.60% | 11.28% | 11.84% | 9.57% | 7.61% | 9.86% |
| ROE % | 11.83% | 11.88% | 13.44% | 8.48% | 5.42% | 6.48% |
| ROCE % | 14.79% | 13.16% | 12.09% | 8.95% | 7.42% | 8.43% |
| 8.36% | 7.30% | 6.81% | 4.22% | 3.22% | 4.35% | |
| EFFICIENCY | - | - | - | - | - | - |
| Debtor Days | 36 | 40 | 38 | 50 | 51 | 53 |
| Inventory Days | 48 | 51 | 43 | 40 | 51 | 73 |
| Payable Days | 46 | 90 | 123 | 140 | 117 | 108 |
| 38 | 1 | -43 | -50 | -14 | 19 | |
| FINANCIAL HEALTH | - | - | - | - | - | - |
| Debt to Equity (x) | 0.20x | 0.43x | 0.73x | 0.69x | 0.31x | 0.31x |
| Interest Coverage (x) | 6.41x | 6.30x | 7.51x | 3.85x | 3.09x | 3.52x |
| 1.52x | 1.01x | 1.07x | 1.03x | 1.21x | 1.40x | |
| GROWTH | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 14.17% | 35.35% | 4.00% | 14.99% | 15.80% |
| Operating Profit Growth % | 0.00% | 10.29% | 32.47% | 20.41% | 9.56% | 22.73% |
| Net Profit Growth % | 0.00% | 11.01% | 42.10% | -15.95% | -8.53% | 49.96% |
| 0.00% | 0.00% | 0.00% | 0.00% | -19.92% | 48.59% | |
| VALUATION | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 68.64x | 26.55x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 3.11x | 1.64x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 21.17x | 10.80x |
Mar 2020
- EPS (₹)
- 6.43
- Book Value (₹)
- 54.35
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 11.16
- Operating Margin %
- 25.99%
- Net Margin %
- 11.60%
- ROE %
- 11.83%
- ROCE %
- 14.79%
- 8.36%
- Debtor Days
- 36
- Inventory Days
- 48
- Payable Days
- 46
- 38
- Debt to Equity (x)
- 0.20x
- Interest Coverage (x)
- 6.41x
- 1.52x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 6.84
- Book Value (₹)
- 63.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 12.00
- Operating Margin %
- 25.11%
- Net Margin %
- 11.28%
- ROE %
- 11.88%
- ROCE %
- 13.16%
- 7.30%
- Debtor Days
- 40
- Inventory Days
- 51
- Payable Days
- 90
- 1
- Debt to Equity (x)
- 0.43x
- Interest Coverage (x)
- 6.30x
- 1.01x
- Revenue Growth %
- 14.17%
- Operating Profit Growth %
- 10.29%
- Net Profit Growth %
- 11.01%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 8.87
- Book Value (₹)
- 74.45
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.52
- Operating Margin %
- 24.57%
- Net Margin %
- 11.84%
- ROE %
- 13.44%
- ROCE %
- 12.09%
- 6.81%
- Debtor Days
- 38
- Inventory Days
- 43
- Payable Days
- 123
- -43
- Debt to Equity (x)
- 0.73x
- Interest Coverage (x)
- 7.51x
- 1.07x
- Revenue Growth %
- 35.35%
- Operating Profit Growth %
- 32.47%
- Net Profit Growth %
- 42.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 6.70
- Book Value (₹)
- 91.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.57
- Operating Margin %
- 28.45%
- Net Margin %
- 9.57%
- ROE %
- 8.48%
- ROCE %
- 8.95%
- 4.22%
- Debtor Days
- 50
- Inventory Days
- 40
- Payable Days
- 140
- -50
- Debt to Equity (x)
- 0.69x
- Interest Coverage (x)
- 3.85x
- 1.03x
- Revenue Growth %
- 4.00%
- Operating Profit Growth %
- 20.41%
- Net Profit Growth %
- -15.95%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 5.37
- Book Value (₹)
- 118.41
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.66
- Operating Margin %
- 25.03%
- Net Margin %
- 7.61%
- ROE %
- 5.42%
- ROCE %
- 7.42%
- 3.22%
- Debtor Days
- 51
- Inventory Days
- 51
- Payable Days
- 117
- -14
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 3.09x
- 1.21x
- Revenue Growth %
- 14.99%
- Operating Profit Growth %
- 9.56%
- Net Profit Growth %
- -8.53%
- -19.92%
- P/E (x)
- 68.64x
- P/B (x)
- 3.11x
- Dividend Yield %
- 0.00%
- 21.17x
Mar 2025
- EPS (₹)
- 7.97
- Book Value (₹)
- 128.75
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 17.49
- Operating Margin %
- 27.99%
- Net Margin %
- 9.86%
- ROE %
- 6.48%
- ROCE %
- 8.43%
- 4.35%
- Debtor Days
- 53
- Inventory Days
- 73
- Payable Days
- 108
- 19
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 3.52x
- 1.40x
- Revenue Growth %
- 15.80%
- Operating Profit Growth %
- 22.73%
- Net Profit Growth %
- 49.96%
- 48.59%
- P/E (x)
- 26.55x
- P/B (x)
- 1.64x
- Dividend Yield %
- 0.00%
- 10.80x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-03 - Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call.
- Copy of Newspaper Publication
2026-08-01 - Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026